Literature DB >> 2426597

Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.

T H Ottenhoff, D G Elferink, P R Klatser, R R de Vries.   

Abstract

Leprosy is a chronic infectious disease caused by Mycobacterium leprae. A characteristic feature of the disease is its remarkable spectrum of clinical symptoms correlating with the cellular immune responsiveness of the patient. At one pole of this spectrum are tuberculoid patients displaying both acquired cell-mediated immunity and delayed type hypersensitivity against the bacillus. At the other pole are lepromatous patients which show a specific T-cell unresponsiveness against M. leprae. In between those two poles variable degrees of tuberculoid and lepromatous features may be seen in borderline leprosy patients. Thus far, studies on the mechanism of the antigen specific unresponsiveness in lepromatous leprosy have been contradictory and difficult to interpret, probably because of the use of heterogeneous cell populations in those experiments. We have now succeeded in cloning M. leprae stimulated T-helper (TH) as well as T-suppressor (TS) cells from a borderline lepromatous patient. The TS-clones of this patient specifically suppress responses of peripheral TH cells as well as TH clones induced by both M. leprae and other mycobacteria, but not unrelated antigen or mitogen. These TS cells also completely suppress TH cell responses against a M. leprae specific protein with a relative molecular mass of 36,000 (36K), suggesting the presence of a suppression inducing determinant on this 36K M. leprae protein.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426597     DOI: 10.1038/322462a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  43 in total

1.  Phenotypic analysis of peripheral CD4+ CD8+ T cells in the rat.

Authors:  E Kenny; D Mason; A Pombo; F Ramírez
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

2.  Serological monitoring of previously treated lepromatous patients during a course of multiple immunotherapy treatments with heat-killed Mycobacterium leprae and BCG.

Authors:  J T Douglas; D S Hirsch; T T Fajardo; L S Guido; P R Klatser
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

Review 3.  Immunopathology of leprosy granulomas.

Authors:  R L Modlin; T H Rea
Journal:  Springer Semin Immunopathol       Date:  1988

Review 4.  Immunological study of the defined constituents of mycobacteria.

Authors:  J Ivanyi; K Sharp; P Jackett; G Bothamley
Journal:  Springer Semin Immunopathol       Date:  1988

5.  Defective intralesional interferon-gamma activity in patients with lepromatous leprosy.

Authors:  B Volc-Platzer; H Stemberger; T Luger; T Radaszkiewicz; G Wiedermann
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

6.  Preferential restriction of minor alloantigen-specific suppressor T cells to I-E rather than I-A molecules.

Authors:  N K Nanda
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

Review 7.  Immune suppression genes.

Authors:  D B Oliveira; N A Mitchison
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

8.  The use of antigen-bearing nitrocellulose particles derived from Western blots to study proliferative responses to 27 antigenic fractions from Mycobacterium leprae in patients and controls.

Authors:  E Filley; C Abou-Zeid; M Waters; G Rook
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

9.  A factor from CD8 cells of human immunodeficiency virus-infected patients suppresses HLA self-restricted T helper cell responses.

Authors:  M Clerici; E Roilides; C S Via; P A Pizzo; G M Shearer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

10.  Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4.

Authors:  Simone A Joosten; Krista E van Meijgaarden; Nigel D L Savage; Tjitske de Boer; Frédéric Triebel; Annemieke van der Wal; Emile de Heer; Michèl R Klein; Annemieke Geluk; Tom H M Ottenhoff
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.